Tumour necrosis factor alpha and its promoter polymorphisms' role in the phenotypic expression of hemochromatosis

Scandinavian Journal of Gastroenterology

Volumn 38, Issue 8, 2003, Pages 871-877

  Distante, S ^a   Elmberg, M ^b   Foss Haug, K B ^b   Ovstebo R ^b   Berg, J P ^b   Kierulf, P ^b   Hultcrantz, R ^b   Bell, H ^b  

^a AKER UNIVERSITY HOSPITAL   (Norway)

^b NONE

Author keywords

C282Y gene mutation; Hemochromatosis; Peripheral blood mononuclear cell; Phenotypic expression; TNF polymorphisms

Indexed keywords

FERRITIN; LIPOPOLYSACCHARIDE; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DNA POLYMORPHISM; FEMALE; GENE EXPRESSION; GENE MUTATION; HEMOCHROMATOSIS; HOMOZYGOSITY; HUMAN; HUMAN CELL; IRON METABOLISM; LIVER CIRRHOSIS; MALE; MONONUCLEAR CELL; PHENOTYPE; PREVALENCE; PRIORITY JOURNAL; PROMOTER REGION; SCREENING; SIDEROSIS;

ADULT; AGED; AGED, 80 AND OVER; FEMALE; GENE EXPRESSION; HEMOCHROMATOSIS; HISTOCOMPATIBILITY ANTIGENS CLASS I; HOMOZYGOTE; HUMANS; MALE; MEMBRANE PROTEINS; MIDDLE AGED; MUTATION; PHENOTYPE; POLYMORPHISM, GENETIC; PROMOTER REGIONS (GENETICS); TUMOR NECROSIS FACTOR-ALPHA;

EID: 0042929566     PISSN: 00365521     EISSN: None     Source Type: Journal    
DOI: 10.1080/00365520310003444     Document Type: Article

References (39)

1. Edwards CQ, Griffen LM, Goldgar D, Drummond C, Skolnick MH, Kushner JP. Prevalence of hemochromatosis among 11,065 presumably healthy blood donors. N Engl J Med 1988;318:1355-62.
2. Feder JN, Gnirke A, Thomas W, Tsuchihashi Z, Ruddy DA, Basava A, et al. A novel MHC class I-like gene is mutated in patients with hereditary haemochromatosis [see comments]. Nat Genet 1996;13:399-408.
3. Cardoso EM, Stal P, Hagen K, Cabeda JM, Esin S, De Sousa M, et al. HFE mutations in patients with hereditary haemochromatosis in Sweden. J Intern Med 1998;243:203-8.
4. Bell H, Berg JP, Undlien DE, Distante S, Raknerud N, Heier HE, et al. The clinical expression of hemochromatosis in Oslo, Norway. Excessive oral iron intake may lead to secondary hemochromatosis even in HFE C282Y mutation negative subjects. Scand J Gastroenterol 2000;35:1301-7.
5. Adams PC. Nonexpressing homozygotes for C282Y hemochromatosis: minority or majority of cases? Mol Genet Metab 2000; 71:81-6.
6. Bassett ML, Wilson SR, Cavanaugh JA. Penetrance of HFE related hemochromatosis in perspective. Hepatology 2002;36:500-3.
7. Beutler E, Felitti VJ, Koziol JA, Ho NJ, Gelbart T. Penetrance of 845G→A (C282Y) HFE hereditary haemochromatosis mutation in the USA. Lancet 2002;359:211-8.
8. Jackson HA, Carter K, Darke C, Guttridge MG, Ravine D, Hutton RD, et al. HFE mutations, iron deficiency and overload in 10,500 blood donors. Br J Haematol 2001;114:474-84.
9. Asberg A, Hveem K, Thorstensen K, Ellekjter E, Kannelonning K, Fjosne U, et al. Screening for hemochromatosis: high prevalence and low morbidity in an unselected population of 65,238 persons. Scand J Gastroenterol 2001;36:1108-15.
10. Powell LW, Subramaniam VN, Yapp TR. Haemochromatosis in the new millennium. J Hepatol 2000;32:48-62.
11. De Sousa M. T lymphocytes and iron overload: novel correlations of possible significance to the biology of the immunological system. Memorias do Instituto Oswaldo Cruz; 1992. p. 87.
12. Reimao R, Porto G, De Sousa M. Stability of CD4/CD8 ratios in man: new correlation between CD4/CD8 profiles and iron overload in idiopathic haemochromatosis patients. CR Acad Sci III 1991;313:481-7.
13. Konijn AM. Iron metabolism in inflammation. Baillieres Clin Hematol; 1994. p. 829-49.
14. Tsuji Y, Miller LL, Miller SC, Torti SV, Torti FM. Tumor necrosis factor-alpha and interleukin 1-alpha regulate transferrin receptor in human diploid fibroblasts. Relationship to the induction of ferritin heavy chain. J Biol Chem 1991;266:7257-61.
15. Alvarez-Hernandez X, Liceaga J, McKay IC, Brock JH. Induction of hypoferremia and modulation of macrophage iron metabolism by tumor necrosis factor. Lab Invest 1989;61:319-22.
16. Moldawer LL, Marano MA, Wei H, Fong Y, Silen ML, Kuo G, et al. Cachectin/tumor necrosis factor-alpha alters red blood cell kinetics and induces anemia in vivo. FASEB J 1989;3:1637-43.
17. Ten Elshof AE, Brittenham GM, Chorney KA, Page MJ, Gerhard G, Cable EE, et al. Gamma delta intraepithelial lymphocytes drive tumor necrosis factor-alpha responsiveness to intestinal iron challenge: relevance to hemochromatosis. Immunol Rev 1999;167:223-32.
18. Gordeuk VR, Ballou S, Lozanski G, Brittenham GM. Decreased concentrations of tumor necrosis factor-alpha in supernatants of monocytes from homozygotes for hereditary hemochromatosis. Blood 1992;79:1855-60.
19. Recalcati S, Pometta R, Levi S, Conte D, Cairo G. Response of monocyte iron regulatory protein activity to inflammation: abnormal behavior in genetic hemochromatosis. Blood 1998;91:2565-72.
20. Fargion S, Valenti L, Dongiovanni P, Scaccabarozzi A, Fracanzani AL, Taioli E, et al. Tumor necrosis factor alpha promoter polymorphisms influence the phenotypic expression of hereditary hemochromatosis. Blood 2001;97:3707-12.
21. Wilson AG, di Giovine FS, Blakemore AI, Duff GW. Single base polymorphism in the human tumour necrosis factor alpha (TNF alpha) gene detectable by NcoI restriction of PCR product. Hum Mol Genet 1992;1:353.
22. Fanning GC, Bunce M, Black CM, Welsh KI. Polymerase chain reaction haplotyping using 3′ mismatches in the forward and reverse primers: application to the biallelic polymorphisms of tumor necrosis factor and lymphotoxin alpha. Tissue Antigens 1997;50:23-31.
23. Wilson AG, Symons JA, McDowell TL, McDevitt HO, Duff GW. Effects of a polymorphism in the human tumor necrosis factor alpha promoter on transcriptional activation. Proc Natl Acad Sci USA 1997;94:3195-9.
24. Pociot F, Briant L, Jongeneel CV, Molvig J, Worsaae H, Abbal M, et al. Association of tumor necrosis factor (TNF) and class II major histocompatibility complex alleles with the secretion of TNF-alpha and TNF-beta by human mononuclear cells: a possible link to insulin-dependent diabetes mellitus. Eur J Immunol 1993;23:224-31.
25. Wilson AG, Gordon C, di Giovine FS, de Vries N, van de Putte LB, Emery P, et al. A genetic association between systemic lupus erythematosus and tumor necrosis factor alpha. Eur J Immunol 1994;24:191-5.
26. Cookson S, Constantini PK, Clare M, Underhill JA, Bernal W, Czaja AJ, et al. Frequency and nature of cytokine gene polymorphisms in type 1 autoimmune hepatitis. Hepatology 1999;30:851-6.
27. Mitchell SA, Grove J, Spurkland A, Boberg KM, Fleming KA, Day CP, et al. Association of the tumour necrosis factor alpha -308 but not the interleukin 10 -627 promoter polymorphism with genetic susceptibility to primary sclerosing cholangitis. Gut 2001;49:288-94.
28. Jones DE, Watt FE, Grove J, Newton JL, Daly AK, Gregory WL, et al. Tumour necrosis factor-alpha promoter polymorphisms in primary biliary cirrhosis. J Hepatol 1999;30:232-6.
29. Kaluza W, Reuss E, Grossmann S, Hug R, Schopf RE, Galle PR, et al. Different transcriptional activity and in vitro TNF-alpha production in psoriasis patients carrying the TNF-alpha 238A promoter polymorphism. J Invest Dermatol 2000;114:1180-3.
30. Beutler E, Gelbart T. Tumor necrosis factor alpha promoter polymorphisms and liver abnormalities of homozygotes for the 845G > A(C282Y) hereditary hemochromatosis mutation. Blood 2002;100:2268-9.
31. Eggesbo JB, Hjermann I, Lund PK, Joo GB, Ovstebo R, Kierulf P. LPS-induced release of IL-1 beta, IL-6, IL-8, TNF-alpha and sCD14 in whole blood and PBMC from persons with high or low levels of HDL-lipoprotein. Cytokine 1994;6:521-9.
32. Lund PK, Joo GB, Westvik AB, Ovstebo R, Kierulf P. Isolation of monocytes from whole blood by density gradient centrifugation and counter-current elutriation followed by cryopreservation: six years' experience. Scand J Clin Lab Invest 2000;60:357-65.
33. Osnes LT, Westvik AB, Kierulf P. Procoagulant and profibrinolytic activities of cryopreserved human monocytes. Thromb Res 1994;76:373-83.
34. Coligan JE editor.. Current protocols in immunology. Green Publishing Associates Inc and John Wiley & Sons. Inc, USA; 1994. p. ch. 5.4.8.
35. Brandtzaeg P, Øvstebø R, Kierulf P. Quantitative detection of bacterial LPS in clinical specimens. In: Pollard AJ, Maiden MCJ, editors. Meningococcal disease protocols. Totowa, NJ: Humana Press; 2001.
36. Distante S, Berg JP, Lande K, Haug E, Bell H. HFE gene mutation (C282Y) and phenotypic expression among a hospitalised population in a high prevalence area of haemochromatosis. Gut 2000;47:575-9.
37. Piperno A, Sampietro M, Pietrangelo A, Arosio C, Lupica L, Montosi G, et al. Heterogeneity of hemochromatosis in Italy. Gastroenterology 1998;114:996-1002.
38. Donaldson PT. TNF gene polymorphisms in primary biliary cirrhosis: a critical appraisal. J Hepatol 1999;31:366-8.
39. Wilson AG. Genetics of tumour necrosis factor (TNF) in autoimmune liver diseases: red hot or red herring? J Hepatol 1999;30:331-3.